Sulbactam sodium/ampicillin sodium (SBT/ABPC) 3g, QID for the treatment of moderate to severe community-acquired pneumonia (CAP): the first evidence from Japan
Author(s) -
S Kohno,
Kazuhiro Tateda,
Hiroshige Mikamo,
Junichi Kadota,
Y Niki,
Rio Itamura
Publication year - 2012
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2012.05.833
Subject(s) - medicine , moraxella catarrhalis , streptococcus pneumoniae , haemophilus influenzae , community acquired pneumonia , pneumonia , gastroenterology , cefixime , antibiotics , cephalosporin , microbiology and biotechnology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom